Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rapport Therapeutics (RAPP) EBIT Margin (2026)

Rapport Therapeutics (RAPP) has 1 years of EBIT Margin data on record, last reported at 121.08% in Q1 2026.